Investment Rating - The report gives a "Buy" rating for 延江股份 (Yanjing Co.) based on its expected high growth phase starting in 2025, with projected net profits of 0.6 billion, 1.4 billion, and 2.0 billion yuan for 2025, 2026, and 2027 respectively, indicating a CAGR of +94% [19] Core Views - The textile and apparel sector has shown weaker performance compared to the market, with the SW textile and apparel index declining by 0.1% from September 29 to September 30, underperforming the SW All A index by 2.1 percentage points [5][6] - Recent industry data indicates that from January to August, the total retail sales of clothing, shoes, and textiles reached 940 billion yuan, a year-on-year increase of 2.9% [5][35] - The report highlights a significant increase in Australian wool prices, which are expected to benefit 新澳股份 (New Australia Co.) as it capitalizes on the current wool cycle [11][12] Summary by Sections Textile Sector - The Australian wool auction prices have reached record highs, with the Eastern Market Composite Index increasing by 112 Australian cents per kilogram to 1565 Australian cents per kilogram, marking a 7.7% increase month-on-month and a 41.8% increase year-on-year [11] - 新澳股份 is positioned to benefit from this wool price increase, with expectations of improved performance starting in Q4 2025 due to favorable inventory levels and order trends [11][12] - The report notes that the textile manufacturing sector is currently facing challenges due to U.S. tariffs, but high-quality manufacturers are expected to recover as market conditions improve [12] Apparel Sector - NIKE's FY26Q1 results showed a revenue of 11.7 billion USD, a 1% year-on-year increase, although net profit fell by 31% [13][14] - The report anticipates that NIKE will gradually recover, with significant opportunities arising from its operational improvements [14] - The domestic retail environment is expected to improve, with various initiatives aimed at boosting consumer spending, particularly in the sportswear segment [14] Company Highlights - 延江股份 is recognized for its strong position in the global supply chain for hygiene materials, with a projected high growth phase beginning in 2025 due to increased orders [15][19] - 稳健医疗 (Steady Medical) has shown resilience with a compound annual growth rate of 14% in revenue from 2019 to 2024, and plans to continue focusing on high-quality growth in both its medical and consumer product segments [20][21] - The report emphasizes the importance of brand strength and innovation in driving growth for companies like 稳健医疗, which has successfully navigated multiple economic cycles [20][21]
纺织服装行业周报:本周发布延江股份深度,澳毛大周期推荐新澳股份-20251008